We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-14.08%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.9B
AUM Growth
-$2.54B
Cap. Flow
-$55.2M
Cap. Flow %
-0.43%
Top 10 Hldgs %
24%
Holding
2,963
New
235
Increased
680
Reduced
1,092
Closed
109

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Healthcare 13.41%
3 Financials 11.93%
4 Consumer Discretionary 10.01%
5 Industrials 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULC icon
2876
Fulcrum Therapeutics
FULC
$284M
-15,001
Closed -$355K
GAN
2877
DELISTED
GAN Ltd
GAN
-14,646
Closed -$70.6K
GOCO
2878
DELISTED
GoHealth
GOCO
-186
Closed -$3.3K
HBIO icon
2879
Harvard Bioscience
HBIO
$28.1M
-1,684
Closed -$105K
HOFT icon
2880
Hooker Furnishings Corp
HOFT
$160M
-8,421
Closed -$159K
HYFM icon
2881
Hydrofarm Holdings
HYFM
$8M
-2,195
Closed -$332K
IMUX icon
2882
Immunic
IMUX
$217M
-1,188
Closed -$134K
IMVT icon
2883
Immunovant
IMVT
$8.8B
-25,184
Closed -$139K
IVVD icon
2884
Invivyd
IVVD
$216M
-38,979
Closed -$178K
KRNT icon
2885
Kornit Digital
KRNT
$815M
-3,100
Closed -$256K
KRON
2886
DELISTED
Kronos Bio
KRON
-24,534
Closed -$177K
LAB icon
2887
Standard BioTools
LAB
$312M
-35,462
Closed -$127K
LE icon
2888
Lands' End
LE
$391M
-7,602
Closed -$129K
LITS
2889
Lite Strategy Inc
LITS
$31.4M
-3,998
Closed -$48.2K
DFTX
2890
Definium Therapeutics
DFTX
$5.75B
-9,745
Closed -$162K
MTRX icon
2891
Matrix Service
MTRX
$330M
-14,152
Closed -$116K
NRIM icon
2892
Northrim BanCorp
NRIM
$599M
-13,936
Closed -$152K
NVEC icon
2893
NVE Corp
NVEC
$591M
-3,201
Closed -$174K
OMER icon
2894
Omeros
OMER
$992M
-28,967
Closed -$174K
ORMP icon
2895
Oramed Pharmaceuticals
ORMP
$178M
-17,360
Closed -$150K
PRAX icon
2896
Praxis Precision Medicines
PRAX
$10.8B
-1,296
Closed -$198K
PSNL icon
2897
Personalis
PSNL
$1.52B
-20,825
Closed -$171K
RRGB icon
2898
Red Robin
RRGB
$151M
-8,965
Closed -$151K
RYAM icon
2899
Rayonier Advanced Materials
RYAM
$561M
-21,779
Closed -$143K
RYTM icon
2900
Rhythm Pharmaceuticals
RYTM
$8.1B
-24,442
Closed -$282K

Similar funds

MetLife Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, MetLife Investment Management held 2,963 positions worth $12.9B, down 16% from $15.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

MetLife Investment Management's Q2 2022 filing shows 235 new, 680 increased, 1,092 reduced and 109 closed positions. Its largest new stake was Airbnb: 23,229 shares worth $2.07M. The largest sale was Apple, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2022 buy was Airbnb: 23,229 shares worth $2.07M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $119M increase.
  • MetLife Investment Management's biggest Q2 2022 reduction was Apple, cutting an estimated $21.3M.
  • MetLife Investment Management fully exited Cerner Corp in Q2 2022, selling an estimated $7.49M.
  • MetLife Investment Management's ten largest holdings make up 24% of its $12.9B portfolio in Q2 2022.
  • MetLife Investment Management opened 235 new positions and closed 109 in Q2 2022.
  • MetLife Investment Management's portfolio value fell 16% quarter-over-quarter to $12.9B.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.